arrow
S

Shuta Ohara

kindai university faculty of medicine
H指数:13
被引数:947

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Perioperative Outcomes and Pathological Response After Neoadjuvant Nivolumab Plus Platinum Chemotherapy in Clinically Node-Negative Non-Small Cell Lung Cancer

ASO 可视化摘要:在临床 N0 期非小细胞肺癌中,新辅助尼鲁单抗联合铂类化疗的围手术期结局及病理学反应

2026-09-300
PRE
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study

抗生素和质子泵抑制剂对局部晚期非小细胞肺癌术前化免疫疗法疗效无影响:一项多中心回顾性研究

2026-02-260
PRE
Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)

手术切除肺腺癌患者中 uncommon EGFR mutations 的生存结局:一项多中心真实世界数据库研究(CReGYT-01 EGFR study)

2026-01-060
PRE
Safety Profile of Neoadjuvant Chemoimmunotherapy with Nivolumab for Patients with Resectable NSCLC in the Real-world (CReGYT-04 Neo-Venus)

纳武利尤单抗新辅助化免疫疗法在可切除非小细胞肺癌患者中的真实世界安全性分析 (CReGYT-04 Neo-Venus)

2025-10-300
PRE
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC

2025年肺癌基础与转化研究进展——聚焦NSCLC的概述与展望

2025-06-030
PRE
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
2025-03-010
OA
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study)
2024-11-211
PRE
Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation - A real-world database study in Japan: The CReGYT-01 EGFR study
2024-04-011
PRE
Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

手术切除的肺癌患者来源的类器官作为生物标志物和药物测试的体外模型的临床相关性

2023-09-014
OA